Ardea Biosciences, Inc. (RDEA) Reports Q3 Loss of $0.84, Sales Miss Expectations
Tweet
Share
E-mailGet Alerts RDEA Hot Sheet
Join SI Premium – FREE
Ardea Biosciences, Inc. (NASDAQ: RDEA) reported Q3 EPS of ($0.84), $0.17 worse than the analyst estimate of ($0.67). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.95 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Paramount Global (PARA) Tops Q2 EPS by 480c
- Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
